---
title: Cefotaxime + Sulbactam
description: >-
  Cefotaxime + Sulbactam is a combined antibiotic medication used to treat a
  wide range of bacterial infections.  Cefotaxime, a third-generation
  cephalosporin antibiotic, works by inhibiting bacterial cell wall synthesis.
  Sulbactam, a beta-lactamase inhibitor, protects cefotaxime from being broken
  ...
is_banned: false
lastModified: '2025-09-22T17:22:08.598Z'
faqs:
  - q: >-
      What is the recommended dosage for Cefotaxime + Sulbactam?**


      **A:**  Adults: 1-2 g IV/IM every 6-12 hours; Children: 50-180 mg/kg/day
      IV/IM divided every 6-8 hours.  Adjust for renal impairment.
    a: >-
      A:**  Adults: 1-2 g IV/IM every 6-12 hours; Children: 50-180 mg/kg/day
      IV/IM divided every 6-8 hours.  Adjust for renal impairment.
  - q: |-
      How is Cefotaxime + Sulbactam administered?**

      **A:** Intravenously (IV) or intramuscularly (IM).
    a: 'A:** Intravenously (IV) or intramuscularly (IM).'
  - q: |-
      What are the common side effects?**

      **A:** Pain at injection site, diarrhea, nausea, vomiting, skin rash.
    a: 'A:** Pain at injection site, diarrhea, nausea, vomiting, skin rash.'
  - q: >-
      What are the serious side effects?**


      **A:**  Allergic reactions (including anaphylaxis), seizures (especially
      with renal impairment), *Clostridium difficile* infection.
    a: >-
      A:**  Allergic reactions (including anaphylaxis), seizures (especially
      with renal impairment), *Clostridium difficile* infection.
  - q: >-
      Can Cefotaxime + Sulbactam be used in pregnant women?**


      **A:** Use with caution if clearly needed, weighing benefits against
      potential fetal risks.
    a: >-
      A:** Use with caution if clearly needed, weighing benefits against
      potential fetal risks.
  - q: >-
      What are the main drug interactions?**


      **A:** Aminoglycosides (increased nephrotoxicity), probenecid,
      anticoagulants.
    a: >-
      A:** Aminoglycosides (increased nephrotoxicity), probenecid,
      anticoagulants.
  - q: |-
      How should dosage be adjusted for renal impairment?**

      **A:**  Reduce the dose based on creatinine clearance.
    a: 'A:**  Reduce the dose based on creatinine clearance.'
  - q: >-
      What infections is Cefotaxime + Sulbactam commonly used to treat?**


      **A:** Respiratory tract infections, urinary tract infections, skin and
      soft tissue infections, intra-abdominal infections, septicemia, and
      bacterial meningitis.
    a: >-
      A:** Respiratory tract infections, urinary tract infections, skin and soft
      tissue infections, intra-abdominal infections, septicemia, and bacterial
      meningitis.
  - q: >-
      What is the role of Sulbactam in this combination?**


      **A:** Sulbactam extends the effectiveness of Cefotaxime by inhibiting
      beta-lactamase enzymes produced by certain bacteria.
    a: >-
      A:** Sulbactam extends the effectiveness of Cefotaxime by inhibiting
      beta-lactamase enzymes produced by certain bacteria.
  - q: >-
      Should dosage be adjusted in patients with liver disease?**


      **A:**  Generally, no dose adjustment is necessary, but caution is advised
      in severe liver disease, especially with concomitant renal dysfunction.
    a: >-
      A:**  Generally, no dose adjustment is necessary, but caution is advised
      in severe liver disease, especially with concomitant renal dysfunction.
---
## **Usage**

Cefotaxime + Sulbactam is a combined antibiotic medication used to treat a wide range of bacterial infections.  Cefotaxime, a third-generation cephalosporin antibiotic, works by inhibiting bacterial cell wall synthesis. Sulbactam, a beta-lactamase inhibitor, protects cefotaxime from being broken down by certain bacterial enzymes, thus broadening its effectiveness against beta-lactamase-producing organisms.

**Pharmacological Classification:**  Antibiotic, Beta-lactam/Beta-lactamase inhibitor combination.

**Mechanism of Action:** Cefotaxime exerts its bactericidal effect by binding to penicillin-binding proteins (PBPs) essential for bacterial cell wall synthesis.  Sulbactam, while having minimal intrinsic antibacterial activity, irreversibly inhibits beta-lactamases, enzymes produced by some bacteria that can inactivate beta-lactam antibiotics. This allows cefotaxime to remain effective against a broader spectrum of bacteria, including those resistant to other cephalosporins.

## **Alternate Names**

No widely recognized alternate names exist for the combination. However, it's crucial to distinguish it from its individual components, cefotaxime and sulbactam.  Numerous brand names exist internationally depending on the manufacturer.

## **How It Works**

**Pharmacodynamics:** Cefotaxime's primary effect is bactericidal, leading to bacterial cell death by disrupting cell wall integrity. Sulbactam enhances this effect by preventing beta-lactamase-mediated degradation of cefotaxime.

**Pharmacokinetics:**  Cefotaxime is administered parenterally (IV or IM) and is well-absorbed.  It achieves therapeutic concentrations in various tissues and fluids, including cerebrospinal fluid. Both cefotaxime and sulbactam are primarily eliminated via renal excretion, with some hepatic metabolism for cefotaxime.

**Mode of Action:** Cefotaxime targets PBPs, particularly PBP1A, PBP1B, and PBP3, crucial for bacterial cell wall cross-linking and synthesis.  Sulbactam forms stable complexes with beta-lactamases, effectively inhibiting their activity and protecting cefotaxime.

**Elimination Pathways:** Primarily renal excretion for both drugs. Cefotaxime undergoes some hepatic metabolism to desacetylcefotaxime, an active metabolite also excreted renally.


## **Dosage**

### **Standard Dosage**

#### **Adults:**
1 to 2 g IV or IM every 6-12 hours.  For severe infections, doses may be increased up to 12 g/day divided into several administrations. Sulbactam component should not exceed 4 g/day.


#### **Children:**
50 to 180 mg/kg/day IV or IM, divided every 6-8 hours.  In severe infections, up to 200 mg/kg/day may be required.  Neonates: 50mg/kg/day in two to four divided doses; in severe infections 150-200 mg/kg/day.

#### **Special Cases:**
- **Elderly Patients:** Dosage adjustments may be necessary based on renal function.
- **Patients with Renal Impairment:** Dose reduction is necessary based on creatinine clearance.
- **Patients with Hepatic Dysfunction:** Generally, no dose adjustment is required, but caution is advised in severe liver disease, especially with concomitant renal impairment.
- **Patients with Comorbid Conditions:** Evaluate individual patient circumstances and adjust dosage if necessary.

### **Clinical Use Cases**
Dosage in clinical settings such as intubation, surgical procedures, mechanical ventilation, and ICU use should be individualized depending upon the type and severity of the infection, the patient's overall condition and renal function. Similar considerations apply for Emergency situations.

### **Dosage Adjustments**
Dose adjustments are crucial for patients with impaired renal or hepatic function.


## **Side Effects**

### **Common Side Effects:**
Pain at the injection site, phlebitis, diarrhea, nausea, vomiting, skin rash.

### **Rare but Serious Side Effects:**
Hypersensitivity reactions (including anaphylaxis), pseudomembranous colitis,  seizures (in patients with renal impairment), Clostridium difficile-associated diarrhea, hepatic dysfunction.

### **Long-Term Effects:**
With prolonged use, superinfections (e.g., fungal infections) can occur.



## **Contraindications**

Hypersensitivity to cefotaxime, sulbactam, or any other cephalosporin or penicillin antibiotic.


## **Drug Interactions**

- Aminoglycosides: Increased risk of nephrotoxicity.
- Probenecid: May decrease cefotaxime elimination.
- Anticoagulants: May potentiate anticoagulant effects.
- Alcohol should be avoided during and shortly after treatment with Cefotaxime + Sulbactam.

## **Pregnancy and Breastfeeding**

Cefotaxime + Sulbactam should be used during pregnancy only if clearly needed. It is excreted in breast milk, so caution should be exercised when administering to breastfeeding mothers.


## **Drug Profile Summary**

- **Mechanism of Action:** Inhibits bacterial cell wall synthesis; Sulbactam protects cefotaxime by inhibiting beta-lactamases.
- **Side Effects:**  Common: Injection site reactions, GI upset, rash. Serious: Hypersensitivity, colitis, seizures.
- **Contraindications:** Hypersensitivity to cephalosporins or penicillins.
- **Drug Interactions:** Aminoglycosides, probenecid, anticoagulants.
- **Pregnancy & Breastfeeding:** Use with caution if benefits outweigh risks.
- **Dosage:**  Adults: 1-2 g IV/IM every 6-12 hours (up to 12 g/day); Children: 50-180 mg/kg/day IV/IM divided every 6-8 hours.
- **Monitoring Parameters:**  Renal function, signs of hypersensitivity, superinfection.

## **Popular Combinations**

This drug is typically not combined with other antibiotics.


## **Precautions**

- Monitor for hypersensitivity reactions.
- Assess renal function, especially in the elderly and those with renal impairment.
- Prolonged use can lead to superinfections.
- Caution in patients with a history of gastrointestinal diseases, particularly colitis.


## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Cefotaxime + Sulbactam?**

**A:**  Adults: 1-2 g IV/IM every 6-12 hours; Children: 50-180 mg/kg/day IV/IM divided every 6-8 hours.  Adjust for renal impairment.

### **Q2: How is Cefotaxime + Sulbactam administered?**

**A:** Intravenously (IV) or intramuscularly (IM).

### **Q3: What are the common side effects?**

**A:** Pain at injection site, diarrhea, nausea, vomiting, skin rash.

### **Q4: What are the serious side effects?**

**A:**  Allergic reactions (including anaphylaxis), seizures (especially with renal impairment), *Clostridium difficile* infection.

### **Q5: Can Cefotaxime + Sulbactam be used in pregnant women?**

**A:** Use with caution if clearly needed, weighing benefits against potential fetal risks.

### **Q6: What are the main drug interactions?**

**A:** Aminoglycosides (increased nephrotoxicity), probenecid, anticoagulants.

### **Q7: How should dosage be adjusted for renal impairment?**

**A:**  Reduce the dose based on creatinine clearance.

### **Q8: What infections is Cefotaxime + Sulbactam commonly used to treat?**

**A:** Respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, septicemia, and bacterial meningitis.

### **Q9:  What is the role of Sulbactam in this combination?**

**A:** Sulbactam extends the effectiveness of Cefotaxime by inhibiting beta-lactamase enzymes produced by certain bacteria.

### **Q10: Should dosage be adjusted in patients with liver disease?**

**A:**  Generally, no dose adjustment is necessary, but caution is advised in severe liver disease, especially with concomitant renal dysfunction.

